Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall readout is in line with the Chinese data that drummed up excitement in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results